The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype
Abstract
Objective To analyze the association of polymorphisms in the tau gene with pathologically confirmed corticobasal degeneration (CBD). Background The authors previously described an extended tau haplotype (H1) that covers the human tau gene and is associated with the development of progressive supranuclear palsy (PSP). The authors now extend this analysis to CBD, a neurodegenerative condition with clinical and neuropathologic similarities to PSP. Like PSP, CBD is associated with accumulation of aggregates containing the 4-repeat isoforms of tau. Because of difficulty in diagnosis of CBD, the authors only analyzed cases with pathologically confirmed CBD. Methods The authors collected 57 unrelated, neuropathologically confirmed cases of CBD. Tau sequencing in these cases failed to show the presence of pathogenic mutations. Polymorphisms that spanned the tau gene were analyzed in all CBD cases and controls. Results Analyzing tau polymorphisms in CBD cases showed that the frequency of H1 and H1/H1 was significantly increased when analyzing all cases and when separating by country of origin. H1 frequency in all CBD cases was 0.921, compared with a control frequency of 0.766 (X(2) = 9.1, p = 0.00255 [1df], OR 3.56 [8.43 > CI 95% > 1.53]). The H1/H1 frequency was also significantly higher at 0.842 compared with 0.596 in age-matched controls (X(2) = 17.42, p = 0.00016, 2df), OR 3.61 [7.05 > CI 95% > 1.85]). Conclusions The CBD tau association described here suggests that PSP and CBD sh…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An association of CBD with the H1 haplotype was first reported in a series of 18 cases (16 corticobasal syndrome patients and two autopsy-confirmed CBD cases)15 and subsequently confirmed in a larger autopsy series of 57 cases16.”
From Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy (2015) · cites this paper as [16]
Citations
Cites
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Self-citationLitvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538
Self-citationGoedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474
Tau is a candidate gene for chromosome 17 frontotemporal dementia
Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374
Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17.
Hong, M., Zhukareva, V., Vogelsberg-Ragaglia, V., Wszolek, Z., Reed, L., Miller, B., Geschwind, D., Bird, T., McKeel, D., Goate, A., et al. (1998) · Science · doi:10.1126/science.282.5395.1914 · Cited by 1,024
Association of an Extended Haplotype in the Tau Gene with Progressive Supranuclear Palsy
Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E., & Hutton, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.711 · Cited by 781
Self-citationTau protein pathology in neurodegenerative diseases
Spillantini, M. G., & Goedert, M. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01337-x · Cited by 683
Structure and novel exons of the human .tau. gene
Andreadis, A., Brown, W. M., & Kosik, K. S. (1992) · Biochemistry · doi:10.1021/bi00158a027 · Cited by 659
Corticodentatonigral Degeneration With Neuronal Achromasia
Rebeiz, J. J., Kolodny, E. H., & Richardson, E. P. (1968) · Archives of Neurology · doi:10.1001/archneur.1968.00470310034003 · Cited by 627
Cited by
Sorted by citations
Items 101–200 of 409
Kara, E., Ling, H., Pittman, A. M., Shaw, K., de Silva, R., Simone, R., Holton, J. L., Warren, J. D., Rohrer, J. D., Xiromerisiou, G., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.04.006 · Cited by 81
Self-citationTau and MAPT genetics in tauopathies and synucleinopathies
Léveillé, E., Ross, O. A., & Gan‐Or, Z. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.09.008 · Cited by 87
Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration
Kouri, N., Carlomagno, Y., Baker, M., Liesinger, A. M., Caselli, R. J., Wszołek, Z. K., Petrucelli, L., Boeve, B. F., Parisi, J. E., Josephs, K. A., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1193-7 · Cited by 89
Self-citationCurrent Understanding of Neurodegenerative Diseases Associated With the Protein Tau
Josephs, K. A. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.04.016 · Cited by 87
Current directions in tau research: Highlights from Tau 2020
Sexton, C. E., Snyder, H. M., Beher, D., Boxer, A. L., Brannelly, P., Brion, J., Buée, L., Cacace, A. M., Chételat, G., Citron, M., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12452 · Cited by 89
Self-citationThe corticobasal syndrome–Alzheimer’s disease conundrum
Hassan, A., Whitwell, J. L., & Josephs, K. A. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.153 · Cited by 80
Evidence suggesting that Homo neanderthalensis contributed the H2 MAPT haplotype to Homo sapiens
Hardy, J., Pittman, A. M., Myers, A., Gwinn, K. A., Fung, H., de Silva, R., Hutton, M. L., & Duckworth, J. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330582 · Cited by 79
Self-citationDawson, H. N., Cantillana, V., Chen, L., & Vitek, M. P. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5492-06.2007 · Cited by 80
Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration
Wakabayashi, K., & Takahashi, H. (2004) · Neuropathology · doi:10.1111/j.1440-1789.2003.00543.x · Cited by 79
Functional MAPT haplotypes: Bridging the gap between genotype and neuropathology
Caffrey, T. M., & Wade‐Martins, R. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.04.006 · Cited by 83
Johnson, G. V. W., & Bailey, C. D. C. (2002) · Journal of Alzheimer's Disease · doi:10.3233/jad-2002-4505 · Cited by 61
Corticobasal Ganglionic Degeneration
Josephs, K. A. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00022-2 · Cited by 75
Kertesz, A., & Muñoz, D. G. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000077155 · Cited by 77
Self-citationKoga, S., Kouri, N., Walton, R. L., Ebbert, M., Josephs, K. A., Litvan, I., Graff‐Radford, N. R., Ahlskog, J. E., Uitti, R. J., van Gerpen, J. A., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1878-z · Cited by 82
Self-citationFrontotemporal Dementia with Tau Pathology
Gasparini, L., Terni, B., & Spillantini, M. G. (2007) · Neurodegenerative Diseases · doi:10.1159/000101848 · Cited by 77
Selective Vulnerability of Brainstem Nuclei in Distinct Tauopathies: A Postmortem Study
Eser, R. A., Ehrenberg, A. J., Petersen, C., Dunlop, S. R., Mejia, M. B., Suemoto, C. K., Walsh, C. M., Rajana, H., Oh, J. Y., Theofilas, P., et al. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx113 · Cited by 71
Frontotemporal Lobar Degeneration: Current Concepts in the Light of Recent Advances
Kumar‐Singh, S., & Broeckhoven, C. V. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00055.x · Cited by 73
Overexpression of Wild-Type Murine Tau Results in Progressive Tauopathy and Neurodegeneration
Adams, S. J., Crook, R., Deture, M. A., Randle, S. J., Innes, A. E., Yu, X., Lin, W.-L., Dugger, B. N., McBride, M., Hutton, M., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090462 · Cited by 71
Self-citationHirano, S., Shinotoh, H., Shimada, H., Aotsuka, A., Tanaka, N., Ota, T., Sato, K., Ito, H., Kuwabara, S., Fukushi, K., et al. (2010) · Brain · doi:10.1093/brain/awq120 · Cited by 72
Ishizawa, T., Ko, L., Cookson, N., Davies, P., Espinoza, M., & Dickson, D. W. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.12.1040 · Cited by 71
Self-citationA geographical cluster of progressive supranuclear palsy in northern France
Caparros-Lefebvre, D., Golbe, L. I., Deramecourt, V., Maurage, C., Huin, V., Buée‐Scherrer, V., Obriot, H., Sablonnière, B., Caparros, F., Buée, L., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001997 · Cited by 72
Self-citationSleep disorders in neurodegenerative diseases
Raggi, A., & Ferri, R. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03034.x · Cited by 68
Colodner, K. J., & Feany, M. Β. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2491-10.2010 · Cited by 71
Deleon, J., & Miller, B. L. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00027-2 · Cited by 75
Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease
Vandrovcová, J., Pittman, A. M., Malzer, E., Abou‐Sleiman, P. M., Lees, A. J., Wood, N. W., & de Silva, R. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.019 · Cited by 67
Self-citationUpdate on epidemiological aspects of progressive supranuclear palsy
Litvan, I. (2003) · Movement Disorders · doi:10.1002/mds.10562 · Cited by 64
Self-citationA minimal length between tau exon 10 and 11 is required for correct splicing of exon 10
Yu, Q., Guo, J. F., & Zhou, J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02477.x · Cited by 63
The ordered assembly of tau is the gain‐of‐toxic function that causes human tauopathies
Goedert, M. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.09.001 · Cited by 67
Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia
Sundar, P. D., Yu, C., Sieh, W., Steinbart, E. J., Garruto, R. M., Oyanagi, K., Craig, U.-K., Bird, T. D., Wijsman, E. M., Galasko, D. R., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl463 · Cited by 63
Clinical differentiation of parkinsonian syndromes: Prognostic and therapeutic relevance
Christine, C. W., & Aminoff, M. J. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.03.032 · Cited by 62
The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers
Sánchez‐Juan, P., Moreno–Grau, S., de Rojas, I., Hernández, I., Valero, S., Alegret, M., Montrreal, L., García‐González, P., Lage, C., López‐García, S., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00327 · Cited by 61
Different Tau Pathology Pattern in Two Clinical Phenotypes of Progressive Supranuclear Palsy
Jellinger, K. A. (2008) · Neurodegenerative Diseases · doi:10.1159/000121388 · Cited by 61
The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer’s disease
Gerrish, A., Russo, G., Richards, A., Moskvina, V., Ivanov, D., Harold, D., Sims, R., Abraham, R., Hollingworth, P., Chapman, J., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110824 · Cited by 49
Self-citationEndoplasmic reticulum stress and its role in various neurodegenerative diseases
Singh, R., Kaur, N., Choubey, V., Dhingra, N., & Kaur, T. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148742 · Cited by 57
PINK, PANK, or PARK? A clinicians' guide to familial parkinsonism
Healy, D. G., Abou‐Sleiman, P. M., & Wood, N. W. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00905-6 · Cited by 57
Self-citationTau is central in the genetic Alzheimer–frontotemporal dementia spectrum
Dermaut, B., Kumar‐Singh, S., Rademakers, R., Theuns, J., Cruts, M., & Broeckhoven, C. V. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.09.005 · Cited by 56
Sha, S. J., Hou, C. E., Viskontas, I. V., & Miller, B. L. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0357 · Cited by 59
Russ, C., Powell, J. F., Zhao, J., Baker, M., Hutton, M., Crawford, F., Mullan, M., Roks, G., Cruts, M., & Lovestone, S. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02289-3 · Cited by 55
Self-citationDistinct Conformers of Assembled Tau in Alzheimer's and Pick's DiseasesPreprint
Goedert, M., Falcon, B., Zhang, W., Ghetti, B. F., & Scheres, S. H. W. (2018) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2018.83.037580 · Cited by 59
Jellinger, K. A. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02028-6 · Cited by 58
Corticobasal degeneration: Selected developments
Lang, A. E. (2003) · Movement Disorders · doi:10.1002/mds.10563 · Cited by 54
Self-citationPhenotypic associations of tau and ApoE in Parkinson's disease
Papapetropoulos, S., Farrer, M. J., Stone, J. T., Milkovic, N. M., Ross, O. A., Calvo, L., McQuorquodale, D., & Mash, D. C. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2006.12.008 · Cited by 52
MAPT H1 haplotype is associated with enhanced α-synuclein deposition in dementia with Lewy bodies
Colom‐Cadena, M., Gelpí, E., Martı́, M. J., Charif, S., Dols‐Icardo, O., Blesa, R., Clarimón, J., & Lleó, A. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.06.015 · Cited by 53
An evaluation of the impact ofMAPT,SNCAandAPOEon the burden of Alzheimer's and Lewy body pathology
Wider, C. W., Ross, O. A., Nishioka, K., Heckman, M. G., Vilariño‐Güell, C., Jasińska‐Myga, B., Erketin-Taner, N., Rademakers, R., Graff‐Radford, N. R., Mash, D. C., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301413 · Cited by 52
Self-citationMeta-analysis of the association between variants in MAPT and neurodegenerative diseases
Zhang, C., Zhu, J., Wan, Y., Tan, L., Wang, H.-F., Yu, J., & Tan, L. (2017) · Oncotarget · doi:10.18632/oncotarget.16690 · Cited by 57
Schottlaender, L., Polke, J. M., Ling, H., MacDoanld, N. D., Tucci, A., Nanji, T., Pittman, A. M., de Silva, R., Holton, J. L., Révész, T., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.08.024 · Cited by 49
Self-citationCorticobasal degeneration: clinical aspects
Bak, T. H., & Hodges, J. R. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01247-x · Cited by 49
Progressive supranuclear palsy and corticobasal degeneration: Lumping versus splitting
Scaravilli, T., TOLOSA, E. S., & Ferrer, I. (2005) · Movement Disorders · doi:10.1002/mds.20536 · Cited by 49
Chasing genes in Alzheimer?s and Parkinson?s disease
Bertoli‐Avella, A. M., Oostra, B. A., & Heutink, P. (2004) · Human Genetics · doi:10.1007/s00439-004-1097-7 · Cited by 48
BEYOND AMYLOID: The Next Generation of Alzheimer's Disease Therapeutics
Seabrook, G. R., Ray, W. J., Shearman, M. S., & Hutton, M. L. (2007) · Molecular Interventions · doi:10.1124/mi.7.5.8 · Cited by 48
Self-citationSaranza, G., Whitwell, J. L., Kovács, G. G., & Lang, A. E. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.10.014 · Cited by 52
Self-citationIngelsson, M., Ramasamy, K., Russ, C., Freeman, S. H., Orne, J. D., Raju, S., Matsui, T., Growdon, J. H., Frosch, M. P., Ghetti, B. F., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0280-z · Cited by 47
Update on progressive supranuclear palsy
Litvan, I. (2004) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-004-0055-z · Cited by 46
Self-citationKatsuse, O., Iseki, E., Arai, T., Akiyama, H., Togo, T., Uchikado, H., Kato, M., de Silva, R., Lees, A. J., & Kosaka, K. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0728-8 · Cited by 46
Self-citationDevelopmental Expression of 4-Repeat-Tau Induces Neuronal Aneuploidy in Drosophila Tauopathy Models
Malmanche, N., Dourlen, P., Gistelinck, M., Demiautte, F., Link, N., Dupont, C., Broeck, L. V., Werkmeister, E., Amouyel, P., Bongiovanni, A., et al. (2017) · Scientific Reports · doi:10.1038/srep40764 · Cited by 48
Possible association of the tau H1/H1 genotype with primary progressive aphasia
Sobrido, M. J., Abu‐Khalil, A., Weıntraub, S., Johnson, N., Quinn, B., Cummings, J. L., Mesulam, M. M., & Geschwind, D. H. (2003) · Neurology · doi:10.1212/01.wnl.0000049473.36612.f2 · Cited by 44
Kertesz, A., & Muñoz, D. G. (2002) · Medical Clinics of North America · doi:10.1016/s0025-7125(02)00011-1 · Cited by 43
Self-citationNew developments in frontotemporal dementia and parkinsonism linked to chromosome 17
Rosso, S. M., & Swieten, J. C. V. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200208000-00004 · Cited by 43
The Tau Gene Haplotype H1 Confers a Susceptibility to Parkinson’s Disease
Zhang, J., Song, Y., Chen, H., & Fan, D. (2004) · European Neurology · doi:10.1159/000082956 · Cited by 43
Zhu, J., Qin, Y., Liu, T., Wang, J., & Zheng, X. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-s5-s5 · Cited by 42
Fung, H., Xiromerisiou, G., Gibbs, J. R., Wu, Y., Eerola, J., Gourbali, V., Hellström, O., Chen, C. M., Duckworth, J., Papadimitriou, A., et al. (2006) · Neurodegenerative Diseases · doi:10.1159/000097301 · Cited by 42
Self-citationGasser, T., Bressman, S., Dürr, A., Higgins, J., Klockgether, T., & Myers, R. H. (2003) · Movement Disorders · doi:10.1002/mds.10338 · Cited by 42
Inflammation in Neurodegenerative Disorders: Friend or Foe?
Galimberti, D., Fenoglio, C., & Scarpini, E. A. (2008) · Current Aging Science · doi:10.2174/1874609810801010030 · Cited by 41
Tolnay, M., & Probst, A. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01251-1 · Cited by 41
Molecular genetic pathways in Parkinson's disease: a review
Jain, S., Wood, N. W., & Healy, D. G. (2005) · Clinical Science · doi:10.1042/cs20050106 · Cited by 42
Self-citationTau Protein in Familial and Sporadic Diseases
Yancopoulou, D., & Spillantini, M. G. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:4:1-2:37 · Cited by 40
de Silva, R., Hardy, J., Crook, J. E., Khan, N. L., Graham, E. A., Morris, C. M., Wood, N. W., & Lees, A. J. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00742-5 · Cited by 40
Self-citationTau-imaging in neurodegeneration
Bischof, G. N., Endepols, H., van Eimeren, T., & Drzezga, A. E. (2017) · Methods · doi:10.1016/j.ymeth.2017.08.003 · Cited by 40
Tan, C., Piao, Y.-S., Kakita, A., Yamada, M., Takano, H., Tanaka, M., Mano, A., Makino, K., Nishizawa, M., Wakabayashi, K., et al. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0933-0 · Cited by 39
Pástor, P., Moreno, F., Clarimón, J., Ruiz, A., Combarros, O., Calero, M., de Munaín, A. L., Bullido, M. J., de Pancorbo, M. M., Carro, E., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150555 · Cited by 42
LeDoux, M. S. (2012) · Advances in genetics · doi:10.1016/b978-0-12-394395-8.00002-5 · Cited by 38
T he MAPT gene is differentially methylated in the progressive supranuclear palsy brain
Huin, V., Deramecourt, V., Caparros-Lefebvre, D., Maurage, C., Duyckaerts, C. J., Kövari, E., Pasquier, F., Buée‐Scherrer, V., Labreuche, J., Behal, H., et al. (2016) · Movement Disorders · doi:10.1002/mds.26820 · Cited by 38
Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases
Schraen‐Maschke, S., Dhaenens, C., Delacourte, A., & Sablonnière, B. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.009 · Cited by 38
An association study of common variation at the MAPT locus with late‐onset Alzheimer's disease
Abraham, R., Sims, R., Carroll, L., Hollingworth, P., O’Donovan, M. C., Williams, J. H., & Owen, M. J. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30951 · Cited by 37
Lace, G., Wharton, S. B., & Ince, P. G. (2007) · Clinical Neuropathology · doi:10.5414/npp26043 · Cited by 37
The H2 MAPT haplotype is associated with familial frontotemporal dementia
Ghidoni, R., Signorini, S. G., Barbiero, L., Sina, E., Cominelli, P., Villa, A., Benussi, L., & Binetti, G. G. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.013 · Cited by 36
Morris, J. C. (2003) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200310000-00010 · Cited by 36
Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy
Ezquerra, M., Pástor, P., Gaig, C., Vidal-Taboada, J. M., Cruchaga, C., Muñoz, E., Martı́, M. J., Valldeoriola, F., Aguilar, M., Calopa, M., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.09.011 · Cited by 35
Clinical and neuropsychological features of corticobasal degeneration
Belfor, N., Amici, S., Boxer, A. L., Kramer, J. H., Gorno‐Tempini, M. L., Rosen, H. J., & Miller, B. L. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.09.013 · Cited by 35
Non-Alzheimer's Disease Dementias: Anatomic, Clinical, and Molecular Correlates
Hou, C. E., Carlin, D. A., & Miller, B. L. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900303 · Cited by 35
Baba, Y., Baker, M., Ber, I. L., Brice, A., Maeck, L., Kohlhase, J., Yasuda, M., Stoppe, G., Bugiani, O., Sperfeld, A.-D., et al. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0632-9 · Cited by 34
Self-citationExtrapyramidal Syndromes in Frontotemporal Degeneration
Kertesz, A., McMonagle, P., & Jesso, S. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9616-1 · Cited by 37
Self-citationAltered Levels and Isoforms of Tau and Nuclear Membrane Invaginations in Huntington’s Disease
Fernández‐Nogales, M., & Lucas, J. J. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00574 · Cited by 32
Is the Saitohin gene involved in neurodegenerative diseases?
Verpillat, P., Ricard, S., Hannequin, D., Dubois, B., Bou, J., Camuzat, A., Pradier, L., Frébourg, T., Brice, A., Clerget‐Darpoux, F., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10384 · Cited by 33
Progressive Supranuclear Palsy and Corticobasal Degeneration
Coughlin, D. G., Dickson, D. W., Josephs, K. A., & Litvan, I. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51140-1_11 · Cited by 33
Self-citationThe Effect of tau genotype on clinical features in FTDP-17
Baba, Y., Tsuboi, Y., Baker, M., Uitti, R. J., Hutton, M. L., Dickson, D. W., Farrer, M. J., Putzke, J. D., Woodruff, B. K., Ghetti, B. F., et al. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.01.003 · Cited by 32
Self-citationA Tangled Web – Tau and Sporadic Parkinson's Disease
Wray, S., & Lewis, P. A. (2010) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00150 · Cited by 31
Linkage disequilibrium and haplotype tagging polymorphisms in the Tau H1 haplotype
Oliveira, S. A., Scott, W. K., Zhang, F., Stajich, J. M., Fujiwara, K., Hauser, M. A., Scott, B. L., Pericak‐Vance, M. A., Vance, J. M., & Martin, E. R. (2004) · Neurogenetics · doi:10.1007/s10048-004-0180-5 · Cited by 31
The Role of MAPT Haplotype H2 and Isoform 1N/4R in Parkinsonism of Older Adults
Valença, G. T., Srivastava, G. P., Filho, J. O., White, C. C., Yu, L., Schneider, J. A., Buchman, A. S., Shulman, J. M., Bennett, D. A., & Jager, P. L. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157452 · Cited by 30
Genetics Underlying Atypical Parkinsonism and Related Neurodegenerative Disorders
Scholz, S. W., & Brás, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161024629 · Cited by 30
Human core duplicon gene families: game changers or game players?
Bekpen, C., & Tautz, D. (2019) · Briefings in Functional Genomics · doi:10.1093/bfgp/elz016 · Cited by 30
Tuite, P., Clark, H. B., Bergeron, C., Bower, M., George‐Hyslop, P. S., Mateva, V., Anderson, J. H., & Knopman, D. S. (2005) · Archives of Neurology · doi:10.1001/archneur.62.9.1453 · Cited by 29
Self-citationLaws, S. M., Perneczky, R., Drzezga, A. E., Diehl‐Schmid, J., Ibach, B., Bäuml, J., Eisele, T., Förstl, H., Kurz, A., & Riemenschneider, M. J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06091456 · Cited by 29
KERTESZ, A. E. (2003) · Movement Disorders · doi:10.1002/mds.10564 · Cited by 29
Self-citationFamilial Semantic Dementia with P301L Mutation in the Tau Gene
Ishizuka, T., Nakamura, M., Ichiba, M., & Sano, A. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000328412 · Cited by 28
Spillantini, M. G. (2001) · JAMA · doi:10.1001/jama.286.18.2324 · Cited by 28
Concomitant progressive supranuclear palsy and chronic traumatic encephalopathy in a boxer
Ling, H., Kara, E., Revesz, T., Lees, A. J., Plant, G. T., Martino, D., Houlden, H., Hardy, J., & Holton, J. L. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-24 · Cited by 27
Self-citationTo what extent did Neanderthals and modern humans interact?
Herrera, K. J., Somarelli, J. A., Lowery, R. K., & Herrera, R. J. (2009) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.2008.00071.x · Cited by 26
Tauopathies: One Disease or Many?
Bouchard, M., & Suchowersky, O. (2011) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100012087 · Cited by 27
Unravelling Genetic Factors Underlying Corticobasal Syndrome: A Systematic Review
Arienti, F., Lazzeri, G., Vizziello, M., Monfrini, E., Bresolin, N., Saetti, M. C., Picillo, M., Franco, G., & Fonzo, A. D. (2021) · Cells · doi:10.3390/cells10010171 · Cited by 29
Metadata
- Authors
- Houlden, H., Baker, M., Morris, H. R., MacDonald, N., Pickering–Brown, S., Adamson, J., Lees, A. J., Rossor, M. N., Quinn, N. P., Kertesz, A., Khan, M. N., Hardy, J., Lantos, P. L., St. George–Hyslop, P., Munoz, D. G., Mann, D., Lang, A. E., Bergeron, C., Bigio, E. H., Litvan, I., Bhatia, K. P., Dickson, D., Wood, N. W., & Hutton, M.
- Affiliations
- St Bartholomew's Hospital (GB)
- From Neurogenetics (Drs. Houlden, Morris, Lees, Rossor, Quinn, Khan, Lantos, and Bhatia), Clinical Neurology and Dementia Research Group, Institute of Neurology, London; Mayo Clinic Jacksonville (Dr. Dickson and M. Baker and J. Adamson), Jacksonville, FL; Department of Gynaecological Oncology (Dr. MacDonald), St. Bartholomew’s Hospital, London; School of Biological Sciences (Dr. Pickering–Brown) and Department of Medicine (Dr. Mann), University of Manchester; Department of Neuropathology (M.N. Khan...
- National Institutes of Health (US)
- ORCID
- Venue
- Neurology
- Published
- 2001-06-26
- Volume
- 56
- Issue
- 12
- Pages
- 1702-1706
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2045671840
- Cited by
- 409
- References
- 32
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 14 · 2023: 9 · 2022: 2 · 2021: 11 · 2020: 11 · 2019: 11 · 2018: 10 · 2017: 14 · 2016: 19 · 2015: 16 · 2014: 16 · 2013: 7 · 2012: 16
- FWCI
- 16.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- corticobasal degeneration, progressive supranuclear palsy, tau gene, tau aggregation, genetic association, neurodegeneration
- MeSH terms
- Genotype, Haplotypes, Humans, Supranuclear Palsy, Progressive, Polymerase Chain Reaction, tau Proteins, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
